We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 3,059

Dentons' pick of global regulatory trends to watch in 2017
  • Dentons
  • Australia, Canada, China, European Union, Germany, Mexico, OECD, United Kingdom, USA
  • February 9 2017

Dentons’ team of regulatory lawyers from key jurisdictions around the world weigh in on regulatory trends to watch in 2017 in the US, Europe, the UK


Competitionantitrust law
  • Dentons
  • USA, Canada, China, European Union, Germany, OECD, United Kingdom, Australia
  • February 9 2017

In the wake of the 2016 elections, we now await the decision as to who will be the "antitrust guard" at the top of the US Department


CIALIS Patent Survives Validity Challenge on Appeal
  • McCarthy Tétrault LLP
  • Canada
  • May 19 2016

Last year we wrote about a trilogy of Federal Court decisions relating to Eli Lilly’s erectile dysfunction (ED) drug CIALIS (tadalafil). While Lilly


The Year Ahead: Ten Top Appeals to Watch in 2017
  • McCarthy Tétrault LLP
  • Canada
  • February 8 2017

The coming year will see our highest court decide a host of appeals of interest to Canadian businesses and professions. The Appeals Monitor is pleased


Data Privacy and Security: A Practical Guide for In-House Counsel
  • Bryan Cave LLP
  • Canada, European Union, Global, USA
  • February 1 2017

Five years ago few legal departments were concerned with - let alone focused on - data privacy


A Most Dysfunctional Application
  • McCarthy Tétrault LLP
  • Canada
  • February 10 2017

The recent decision Baratto v. Merck Canada Inc. presents a rare occasion where the Superior Court of Québec refuses permission to institute a class


Superior Court confirms the validity of royalties paid by a pharmacist to its franchisor
  • Osler Hoskin & Harcourt LLP
  • Canada
  • February 9 2017

Article 49 of the Code of ethics of pharmacists (the Code) precludes pharmacists from sharing profits from the sale of medications or from their fees


‘Up in Smoke’: Benefit Coverage for Medical Marijuana
  • Baker McKenzie
  • Canada
  • February 3 2017

Prime Minister Trudeau portended the legalization of ‘pot’ in Canada in his election campaign. Pending such development, a recent decision by a


Cialis Canadian Patent Knocks Out Double Patenting Challenge
  • Bereskin & Parr LLP
  • Canada
  • January 20 2017

Eli Lilly's Canadian patent on treatment of erectile dysfunction with Cialis continues to defy all challengers. A recent appeal case originated from


Allegations of Invalidity Found Justified on the Basis of Obviousness
  • Borden Ladner Gervais LLP
  • Canada
  • February 15 2017

In this case, the Federal Court dismissed an application for an order of prohibition. The patent at issue claimed pharmaceutical formulations of